Aldeyra Therapeutics was founded in 2004 based on the insight that aldehydes are pivotal mediators of disease. Capturing and removing free aldehydes has the potential to treat and prevent disease as well as slow the progression of chronic disease

from http://www.aldeyra.com/about/

Patents show all

8Issued7Applications

Clinical Trials show all

5Phase 21Phase 3

SEC Filings show all

8-K5510-Q11D410-K3S-11